These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 10746809

  • 1. Iron metabolism in rhEPO-treated hemodialysis patients.
    Schaefer RM, Bahner U.
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S65-8. PubMed ID: 10746809
    [Abstract] [Full Text] [Related]

  • 2. Iron monitoring and supplementation: how do we achieve the best results?
    Schaefer RM, Schaefer L.
    Nephrol Dial Transplant; 1998 Feb; 13 Suppl 2():9-12. PubMed ID: 9566484
    [Abstract] [Full Text] [Related]

  • 3. Erythropoietin and iron.
    Sunder-Plassmann G, Hörl WH.
    Clin Nephrol; 1997 Mar; 47(3):141-57. PubMed ID: 9105761
    [Abstract] [Full Text] [Related]

  • 4. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 5. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C, Grill A, Decostanzi E, Maddalena E, Barbieri S, Martina G, Fop F, Buglione E, Grechi D, David O, Saitta M, Piccoli G.
    Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
    [Abstract] [Full Text] [Related]

  • 6. [The biochemical and hematological assessment of iron metabolism].
    Nathanson S, Deschênes G, Bensman A.
    Arch Pediatr; 1999 Nov; 6(11):1199-204. PubMed ID: 10587746
    [Abstract] [Full Text] [Related]

  • 7. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
    Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.
    J Matern Fetal Med; 1999 Nov; 8(1):1-7. PubMed ID: 10052837
    [Abstract] [Full Text] [Related]

  • 8. Iron requirements in erythropoietin therapy.
    Eschbach JW.
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):347-61. PubMed ID: 15737895
    [Abstract] [Full Text] [Related]

  • 9. Evaluating iron status in hemodialysis patients.
    Enders HM.
    Nephrol Nurs J; 2002 Aug; 29(4):366-70. PubMed ID: 12224370
    [Abstract] [Full Text] [Related]

  • 10. Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron-deficient women: a randomised placebo-controlled study.
    Krafft A, Perewusnyk G, Hänseler E, Quack K, Huch R, Breymann C.
    BJOG; 2005 Apr; 112(4):445-50. PubMed ID: 15777442
    [Abstract] [Full Text] [Related]

  • 11. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
    Chang J, Bird R, Clague A, Carter A.
    Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
    [Abstract] [Full Text] [Related]

  • 12. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
    Beguin Y.
    Med Oncol; 1998 Aug; 15 Suppl 1():S38-46. PubMed ID: 9785336
    [Abstract] [Full Text] [Related]

  • 13. The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients.
    Hackeng CM, Beerenhout CM, Hermans M, Van der Kuy PH, Van der Dussen H, Van Dieijen-Visser MP, Hamulyák K, Van der Sande FM, Leunissen KM, Kooman JP.
    J Nephrol; 2004 Aug; 17(1):107-11. PubMed ID: 15151266
    [Abstract] [Full Text] [Related]

  • 14. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 15. Effect of recombinant human erythropoietin on iron balance in maintenance hemodialysis: theoretical considerations, clinical experience and consequences.
    Grützmacher P, Tsobanelis T, Roth P, Werner E, Vlachojannis J, Kaltwasser J, Kurz P, Scheuermann EH, Schoeppe W.
    Clin Nephrol; 1992 Jun; 38 Suppl 1():S92-7. PubMed ID: 1295714
    [Abstract] [Full Text] [Related]

  • 16. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
    Cermák J, Gregora E, Lachmanová J, Brabec V.
    Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
    [Abstract] [Full Text] [Related]

  • 17. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
    Arndt U, Kaltwasser JP, Gottschalk R, Hoelzer D, Möller B.
    Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
    [Abstract] [Full Text] [Related]

  • 18. [Serum ferritin and iron therapy in patients treated with periodic hemodialysis].
    Docci D, Cenciotti L, Turci F, Salvi G, Mosconi G, Baldrati L.
    Quad Sclavo Diagn; 1982 Dec; 18(4):454-62. PubMed ID: 7186648
    [Abstract] [Full Text] [Related]

  • 19. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy.
    Schaefer RM, Schaefer L.
    J Perinat Med; 1995 Dec; 23(1-2):83-8. PubMed ID: 7658326
    [Abstract] [Full Text] [Related]

  • 20. The measurement and interpretation of serum ferritin.
    Forman DT, Parker SL.
    Ann Clin Lab Sci; 1980 Dec; 10(4):345-50. PubMed ID: 7004332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.